XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)
Class A Ordinary Shares
Common Stock
Class B Ordinary Shares
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2021 $ 0 $ 663 $ 0 $ (16,835,266) $ (16,834,603)
Balance at the beginning (in shares) at Dec. 31, 2021 0 6,628,695      
Increase (Decrease) in Stockholders' Equity          
Remeasurement of Class A ordinary shares subject to possible redemption       (25,233) (25,233)
Net loss       (5,848,813) (5,848,813)
Balance at the end at Mar. 31, 2022   $ 663   (22,709,312) (22,708,649)
Balance at the end (in shares) at Mar. 31, 2022   6,628,695      
Balance at the beginning at Dec. 31, 2021 $ 0 $ 663 0 (16,835,266) (16,834,603)
Balance at the beginning (in shares) at Dec. 31, 2021 0 6,628,695      
Increase (Decrease) in Stockholders' Equity          
Remeasurement of Class A ordinary shares subject to possible redemption         (42,543,190)
Balance at the end at Dec. 31, 2022 $ 0 $ 663 0 (24,393,750) (24,393,087)
Balance at the end (in shares) at Dec. 31, 2022 0 6,628,695      
Increase (Decrease) in Stockholders' Equity          
Remeasurement of Class A ordinary shares subject to possible redemption     (266,784) (2,581,866) (2,848,650)
Amount in excess of the face value over the present value on related party promissory note     68,744   68,744
Contribution of conversion price in excess of fair value of warrants     198,040   198,040
Remeasurement of Class A ordinary shares subject to possible redemption         (2,848,650)
Net loss       (5,227,142) (5,227,142)
Balance at the end at Mar. 31, 2023 $ 0 $ 663 $ 0 $ (32,202,758) $ (32,202,095)
Balance at the end (in shares) at Mar. 31, 2023   6,628,695